Physician profile
Manon Kwon
NPI 1518919430
$3,277.10
in general payments reported to CMS, 2019-2025
7 companies · $3,128 in 2025
The $3,128 reported for 2025 was more than what 97% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.01 · 2020: $92.37 · 2021: $16.13 · 2025: $3,128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,227 · Food and Beverage: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,227.32 |
| Food and Beverage | $900.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,003.51 | 2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Gilead Sciences, INC. | $75.34 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $51.93 | 2025 | |
| Janssen Pharmaceuticals, INC | $51.69 | 2019-2021 | |
| Abbvie INC. | $41.68 | 2025 | |
| Bioventus LLC | $30.47 | 2025 | Supartz Fx Sodium Hyaluronate |
| Csl Behring | $22.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manon Kwon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.